Pure Global
NCT06312267

Reducing Wound Infections Using Bioelectric Wound Dressings

AdventHealth·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
Bioelectric dressing
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
AdventHealth
Location
Kissimmee, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 04, 2024
End date
Mar 01, 2025
Enrollment
20 participants
Primary outcome

Quantitative bacterial count

Summary

The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on
 the pre-operative wound site and post operatively and compared it outcomes to the standard of
 care chlorhexidine skin preparation.

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06312267
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06312267 through Pure Global AI's free database. This phase not specified trial is sponsored by AdventHealth and is currently Recruiting. The study focuses on Surgical Site Infection. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.